These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8684529)

  • 21. Functional evaluation of transplanted kidneys by Gd-DTPA enhanced turbo FLASH MR imaging.
    Nakashima R; Yamashita Y; Tomiguchi S; Tsuji A; Takahashi M
    Radiat Med; 1996; 14(5):251-6. PubMed ID: 8988504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
    Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
    Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interference of gadodiamide injection (OMNISCAN) on the colorimetric determination of serum calcium.
    Normann PT; Frøysa A; Svaland M
    Scand J Clin Lab Invest; 1995 Aug; 55(5):421-6. PubMed ID: 8545600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadodiamide administration causes spurious hypocalcemia.
    Prince MR; Erel HE; Lent RW; Blumenfeld J; Kent KC; Bush HL; Wang Y
    Radiology; 2003 Jun; 227(3):639-46. PubMed ID: 12773671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients?
    Fontseré N; Salinas I; Bonal J; Bayés B; Riba J; Torres F; Rios J; Sanmartí A; Romero R
    Nephrol Dial Transplant; 2006 Aug; 21(8):2152-8. PubMed ID: 16702203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal insufficiency: usefulness of gadodiamide-enhanced renal angiography to supplement CO2-enhanced renal angiography for diagnosis and percutaneous treatment.
    Spinosa DJ; Matsumoto AH; Angle JF; Hagspiel KD; McGraw JK; Ayers C
    Radiology; 1999 Mar; 210(3):663-72. PubMed ID: 10207465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I clinical trial with gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent.
    VanWagoner M; O'Toole M; Worah D; Leese PT; Quay SC
    Invest Radiol; 1991 Nov; 26(11):980-6. PubMed ID: 1743922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic contrast-enhanced magnetic resonance imaging of the kidney: comparison of T1-weighted and T2*-weighted sequences.
    Tsushima Y; Niemi P; Komu M; Dean PB; Haapanen A; Kormano M
    Acad Radiol; 1996 Aug; 3 Suppl 2():S176-8. PubMed ID: 8796555
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacokinetics of gadolinium-DTPA in chronic renal insufficiency requiring dialysis].
    Krahe T; Götz R; Lackner K; Haustein J; Klemenz U; Landwehr P; Heidbreder E; Schuhmann-Giampieri G
    Rofo; 1992 Jun; 156(6):523-6. PubMed ID: 1617171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats.
    Brillet G; Dubois M; Beaufils H; Bourbouze R; Deray G
    Invest Radiol; 1994 Mar; 29(3):352-4. PubMed ID: 8175311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal effects of gadopentetate dimeglumine in patients with normal and impaired renal function.
    Hoffmann U; Fischereder M; Reil A; Fischer M; Link J; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):149-54. PubMed ID: 15946910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioisotopic measurement of glomerular filtration rate in severe chronic renal failure.
    LaFrance ND; Drew HH; Walser M
    J Nucl Med; 1988 Dec; 29(12):1927-30. PubMed ID: 3057129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic aspects of measurement of glomerular filtration rate in the dog: a review.
    Heiene R; Moe L
    J Vet Intern Med; 1998; 12(6):401-14. PubMed ID: 9857332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients.
    Berg KJ; Gjellestad A; Nordby G; Rootwelt K; Djøseland O; Fauchald P; Mehl A; Narverud J; Talseth T
    Nephron; 1989; 53(3):218-22. PubMed ID: 2677807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vivo dissociation of gadolinium chelates in renally impaired rats: a relaxometry study.
    Fretellier N; Idée JM; Dencausse A; Karroum O; Guerret S; Poveda N; Jestin G; Factor C; Raynal I; Zamia P; Port M; Corot C
    Invest Radiol; 2011 May; 46(5):292-300. PubMed ID: 21263333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infusion clearance of subcutaneous iothalamate versus standard renal clearance.
    Sharma AK; Mills MS; Grey VL; Drummond KN
    Pediatr Nephrol; 1997 Dec; 11(6):711-3. PubMed ID: 9438649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic effects of gadodiamide injection and gadopentetate dimeglumine in anesthetized dogs.
    Peters JL; Shaw DD
    Acta Radiol; 1993 Sep; 34(5):510-6. PubMed ID: 8369191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gadodiamide and gadolinium-DTPA as intravenous media in computed tomography].
    Engelbrecht V; Koch JA; Rassek M; Mödder U
    Rofo; 1996 Jul; 165(1):24-8. PubMed ID: 8765359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR imaging of pituitary region lesions with gadodiamide injection.
    Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
    Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications.
    Agarwal R
    Am J Nephrol; 2007; 27(1):92-100. PubMed ID: 17284896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.